Welsh Carson to exit Aptuit

Evotec AG said July 30 that it is buying Aptuit for $300 million. Welsh, Carson, Anderson & Stowe is the seller. Aptuit provides early discovery to mid-phase drug development services in the biotech and pharmaceutical industry.

DealsNorth AmericaUSBriefs